Literature DB >> 8324235

Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway.

M C Galmiche1, V E Koteliansky, J Brière, P Hervé, P Charbord.   

Abstract

In human long-term marrow cultures connective tissue-forming stromal cells are an essential cellular component of the adherent layer where granulomonocytic progenitors are generated from week 2 onward. We have previously found that most stromal cells in confluent cultures were stained by monoclonal antibodies directed against smooth muscle-specific actin isoforms. The present study was carried out to evaluate the time course of alpha-SM-positive stromal cells and to search for other cytoskeletal proteins specific for smooth muscle cells. It was found that the expression of alpha-SM in stromal cells was time dependent. Most of the adherent spindle-shaped, vimentin-positive stromal cells observed during the first 2 weeks of culture were alpha-SM negative. On the contrary, from week 3 to week 7, most interdigitated stromal cells contained stress fibers whose backbone was made of alpha-SM-positive microfilaments. In addition, in confluent cultures, other proteins specific for smooth muscle were detected: metavinculin, h-caldesmon, smooth muscle myosin heavy chains, and calponin. This study confirms the similarity between stromal cells and smooth muscle cells. Moreover, our results reveal that cells in vivo with the phenotype closest to that of stromal cells are immature fetal smooth muscle cells and subendothelial intimal smooth muscle cells; a cell subset with limited development following birth but extensively recruited in atherosclerotic lesions. Stromal cells very probably derive from mesenchymal cells that differentiate along this distinctive vascular smooth muscle cell pathway. In humans, this differentiation seems crucial for the maintenance of granulomonopoiesis. These in vitro studies were completed by examination of trephine bone marrow biopsies from adults without hematologic abnormalities. These studies revealed the presence of alpha-SM-positive cells at diverse locations: vascular smooth muscle cells in the media of arteries and arterioles, pericytes lining capillaries, myoid cells lining sinuses at the abluminal side of endothelial cells or found within the hematopoietic logettes, and endosteal cells lining bone trabeculae. More or less mature cells of the granulocytic series were in intimate contact with the thin cytoplasmic extensions of myoid cells. Myoid cells may be the in vivo counterpart of stromal cells with the above-described vascular smooth muscle phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324235

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  62 in total

1.  Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.

Authors:  T Ueda; N Araki; M Mano; A Myoui; S Joyama; S Ishiguro; H Yamamura; K Takahashi; I Kudawara; H Yoshikawa
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 2.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

Review 3.  Stem cell-derived vascular endothelial cells and their potential application in regenerative medicine.

Authors:  Hera Chaudhury; Eric Raborn; Lauren C Goldie; Karen K Hirschi
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

Review 4.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 5.  Cord-blood mesenchymal stem cells and tissue engineering.

Authors:  Curtis L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells.

Authors:  Jeffrey J Ross; Zhigang Hong; Ben Willenbring; Lepeng Zeng; Brett Isenberg; Eu Han Lee; Morayma Reyes; Susan A Keirstead; E Kenneth Weir; Robert T Tranquillo; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

7.  Microvascular mural cell functionality of human embryonic stem cell-derived mesenchymal cells.

Authors:  Nolan L Boyd; Sara S Nunes; Jenny D Jokinen; Laxminarayanan Krishnan; Yinlu Chen; Kristyn H Smith; Steven L Stice; James B Hoying
Journal:  Tissue Eng Part A       Date:  2011-03-04       Impact factor: 3.845

8.  Bone marrow stem cells for urologic tissue engineering.

Authors:  Dave Shukla; Geoffrey N Box; Robert A Edwards; Darren R Tyson
Journal:  World J Urol       Date:  2008-07-25       Impact factor: 4.226

9.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Authors:  Kenichi Tamama; Chandan K Sen; Alan Wells
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

10.  Endothelio-mesenchymal interaction controls runx1 expression and modulates the notch pathway to initiate aortic hematopoiesis.

Authors:  Charlotte Richard; Cécile Drevon; Pierre-Yves Canto; Gaelle Villain; Karine Bollérot; Aveline Lempereur; Marie-Aimée Teillet; Christine Vincent; Catalina Rosselló Castillo; Miguel Torres; Eileen Piwarzyk; Nancy A Speck; Michèle Souyri; Thierry Jaffredo
Journal:  Dev Cell       Date:  2013-03-25       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.